GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PZ Wind Down PZRXQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About PZ Wind Down

Its shares trade under the ticker PZRXQ. It has been listed since 18 May 2016. In the fiscal year to 31 December 2015, it reported revenue of $375,000 and a net loss of $7.4m. At that date it held total assets of $3.9m and shareholders' equity of −$48.9m.

PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. The company is headquartered in Seattle, Washington. The company went IPO on 2016-05-18. The firm's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The firm's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The firm is headquartered in Seattle.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
18 May 2016
Employees
15

Leadership

Pay as last reported

  • Dr. Steven GillisIndependent Chairman of the Board
  • Dr. Robert OverellPresident, Chief Executive Officer, Principal Accounting Officer, Secretary, Director$1.4m
  • Dr. Sean MonahanVice President - Chemistry
  • Dr. Mary PrieveVice President - Biology
  • Mr. Gordon BrandtChief Medical Officer
  • Mr. James WatsonHead of Corporate Development
  • Dr. Paul JohnsonDirector, since 2007
  • Mr. Brian AtwoodIndependent Director
  • Ms. Michelle GriffinIndependent Director
  • Ms. Peggy PhillipsIndependent Director
  • Dr. John SchmidtIndependent Director
  • Mr. Erin CoxIR Contact Officer, since 2015

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • PZ Wind Down Inc has a strong brand presence in the industry, which helps build trust and credibility among its customers. The company also possesses a highly skilled and experienced workforce that enables them to deliver quality services efficiently. Additionally, PZ Wind Down Inc has a diversified product portfolio, allowing them to cater to various customer needs and preferences.

Weaknesses

  • One major weakness of PZ Wind Down Inc is its heavy dependence on a single supplier for crucial raw materials. This creates a potential risk of supply chain disruption and pricing fluctuations. The company also lacks a strong online presence, which can limit its reach and impact on the target market. Moreover, PZ Wind Down Inc may face challenges in adapting to rapidly evolving technologies in the industry.

Opportunities

  • PZ Wind Down Inc can explore opportunities in expanding its market reach by targeting emerging markets with high growth potential. The company can also consider investing in research and development to develop innovative products and gain a competitive edge. Furthermore, PZ Wind Down Inc can leverage partnerships and collaborations with other industry players to expand its product offerings and strengthen its market position.

Threats

  • One significant threat faced by PZ Wind Down Inc is intensifying competition from both existing and new entrants in the industry. This can potentially impact market share and profitability. Economic uncertainties, such as fluctuating exchange rates and trade policies, may also pose threats to the company's operations. Additionally, regulatory changes and stricter environmental regulations can impose compliance challenges on PZ Wind Down Inc.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.